Large-scale Analysis Finds GLP-1 Agents Do Not Increase Risk of Pancreatic Cancer: New Study

Large-scale Analysis Finds GLP-1 Agents Do Not Increase Risk of Pancreatic Cancer: New Study

Concerns have been raised that the use of glucagon-like peptide-1 receptor agonists (GLP-1) may increase the incidence of pancreatitis or pancreatic cancer, but a large-scale cohort analysis found that this was unfounded. The results of a study on the risk association of pancreatic cancer with the use of GLP-1 agents conducted by Dr. Rachel Dankner … Read more

First clinical trial comparing implantable defibrillator + drug vs. drug alone

First clinical trial comparing implantable defibrillator + drug vs. drug alone

A clinical trial comparing the effectiveness of implantable cardioverter-defibrillator (ICD) implants versus medications in myocardial infarction survivors with heart failure has enrolled the first patient. The PROFID EHRA clinical trial began with the goal of recruiting 3,595 patients in 13 countries. Interest in this clinical trial is focused on the fact that it has been … Read more

Apixaban is better than aspirin in preventing stroke in patients with atrial fibrillation.

Apixaban is better than aspirin in preventing stroke in patients with atrial fibrillation.

A study showed that apixaban is more effective than aspirin for preventing stroke in patients with atrial fibrillation. The results of a clinical trial on apixaban for the prevention of stroke in patients with asymptomatic atrial fibrillation, conducted by researchers including Jeff S. Healy of the Population Health Research Center at McMaster University in Canada, … Read more